Drug & Supplement Interactions

Antineoplastons + Opicapone

Brand name of Opicapone

  • Ongentys

Medically reviewed by

Also reviewed by the HelloPharmacist Editorial Team

Updated July 2026Details about this page

AI is used only to summarize verified clinical information, never the open internet. Our AI policy

The Bottom Line No Known Interaction

We found no known interaction between Antineoplastons and Opicapone in our sources.

This also applies to Ongentys, a brand name of opicapone.

Still Worth Knowing

  • Shared side effects: Although there is no interaction, both can cause some of the same side effects. Taken together, those side effects might add up, and a new symptom can be harder to pin on one or the other.
See the Full Interaction Report

Ask a Question About This Combination

Ask in your own words about taking Antineoplastons with Opicapone. The answer comes from this page’s own records.

Try:

AI answers from this page’s interaction records and our own drug and supplement information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist. How we use AI

Interaction Report

Antineoplastons and Opicapone Interaction Check

No Known Interaction Found

We did not find a documented interaction between Opicapone and Antineoplastons in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

How We Checked

Why No Interaction Is Listed for Opicapone

Antineoplastons has no interaction record with any drug in our interaction database, so this rests on missing data, not on a study that found nothing.

Still wondering about combining Antineoplastons and Opicapone? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
Know someone taking this combination? Share
What to Watch For

Side Effects Antineoplastons and Opicapone Have in Common

3 side effects show up for both Antineoplastons and Opicapone.

  • Each has separately been linked to the effects below. Taken together, they might add up: the same side effect from two sources might be more likely or stronger. No study of the two together says by how much.
  • If one turns up, it can be harder to tell which one is behind it, so tell your pharmacist you take both.
  • One of them is worth acting on rather than waiting out, marked below.
  • Raised blood pressure Worth Acting On Additional detail

    Antineoplastons

    Intravenously, antineoplaston A5 has been associated with palpitations at doses up to 153 mg/kg daily. A 71 year-old male bladder cancer patient experienced chest pressure and irregular heartbeat after receiving intravenous antineoplaston A5 58 mg/kg/day for 5 days. Use of intravenous antineoplaston AS2-1, up to 160 mg/kg daily for over 2 years, has been associated with mild hypertension.

    Source: , the clinical database we license.

    5 references cited
    1. 25608. Burzynski SR, Kubove E, Burzynski B. Phase I clinical studies of antineoplaston A5 injections. Drugs Exp Clin Res 1987;13 Suppl 1:37-43.
    2. 25622. Burzynski SR, Kubove E, Burzynski B. Phase I clinical studies of antineoplaston A5 injections. Drugs Exp Clin Res 1987;13 Suppl 1:37-43.
    3. 25604. Tsuda H, Hara H, Eriguchi N, et al. Toxicological study on antineoplastons A-10 and AS2-1 in cancer patients. Kurume Med J 1995;42(4):241-249. PubMed
    4. 25619. Burzynski SR, Burzynski B, Mohabbat MO. Toxicology studies on antineoplaston AS2-1 injections in cancer patients. Drugs Exp Clin Res 1986;12 Suppl 1:25-35.
    5. 25607. Burzynski SR, Kubove E. Phase I clinical studies of antineoplaston A3 injections. Drugs Exp Clin Res 1987;13 Suppl 1:17-29.

    Opicapone

    Source: Opicapone’s

    It lists this side effect in its Adverse Reactions section.

    Read Opicapone’s label on DailyMed ›
  • Drowsiness / Dizziness Additional detail

    Antineoplastons

    Orally and intravenously, headache, fatigue, sleepiness, ringing in the ears, and numbness have been reported for patients treated with antineoplastons A10 and AS2-1. Dizziness has also been noted for some patients treated with oral antineoplaston A10 or intravenous antineoplaston A3.

    Source: , the clinical database we license.

    6 references cited
    1. 25593. Buckner JC, Malkin MG, Reed E, et al. Phase II study of antineoplastons A10 (NSC 648539) and AS2-1 (NSC 620261) in patients with recurrent glioma. Mayo Clin Proc 1999;74(2):137-145. PubMed
    2. 25601. Burzynski SR, Conde AB, Peters A, et al. A retrospective study of antineoplastons A10 and AS2-1 in primary brain tumors. Clin Drug Invest 1999;18(1):1-10.
    3. 25603. Burzynski SR, Lewy RI, Weaver RA, et al. Phase II study of antineoplaston A10 and AS2-1 in patients with recurrent diffuse intrinsic brain stem glioma: a preliminary report. Drugs R D 2003;4(2):91-101. PubMed
    4. 25610. Burzynski SR, Weaver RA, Lewy RI, et al. Phase II study of antineoplaston A10 and AS2-1 in children with recurrent and progressive multicentric glioma : a preliminary report. Drugs R D 2004;5(6):315-326. PubMed
    5. 25620. Burzynski SR, Kubove E. Toxicology studies on antineoplaston A10 injections in cancer patients. Drugs Exp Clin Res 1986;12 Suppl 1:47-55.
    6. 20101. Burzynski SR, Mohabbat MO, Burzynski B. Human toxicology studies on oral formulation of Antineoplaston A10. Drugs Exp Clin Res 1984;10(12):891-909.

    Opicapone

    Source: Opicapone’s

    It lists this side effect in its Adverse Reactions section.

    Read Opicapone’s label on DailyMed ›

Reported for Antineoplastons but not commonly for Opicapone: an irregular heartbeat, ringing in the ears, stomach pain and chest pain.

Note: Effects for Opicapone come from the Adverse Reactions section of its FDA label; effects for Antineoplastons come from the Natural Medicines adverse-effect record, quoted above. Where a percentage is shown, it is the share of 2,261 voluntary FDA FAERS reports for Opicapone that mention that effect — a reporting proportion, not an incidence rate and not evidence the drug caused it. The two sources word some effects differently, so we match them by meaning.

If You Decide to Take Both
  • Add one new thing at a time, and note the date you started it.
  • A start date turns “I’ve been feeling off” into something a pharmacist can work with.
  • Do not stop a prescribed medicine on your own.
  • Check with your pharmacist or doctor before changing any medicine or supplement, especially if you take several or have an ongoing health condition.

Your Whole Routine

Your Other Medicines and Supplements

Alternatives for the Same Use

Other Supplements for the Same Uses as Antineoplastons, and How They Mix With Opicapone

Choosing a supplement while you take Opicapone? Pick what you use Antineoplastons for to see other options studied for it, and whether each has a documented interaction with Opicapone.

What do you take Antineoplastons for?

For Prostate Cancer

None of them has a documented interaction with Opicapone.

3 other supplements have at least some evidence of a benefit for prostate cancer. Antineoplastons itself is graded for it.

  • Lycopene Graded No Known Interaction
  • Strontium Graded No Known Interaction
  • Sulforaphane Graded No Known Interaction

For Colorectal Cancer

None of them has a documented interaction with Opicapone.

2 other supplements have at least some evidence of a benefit for colorectal cancer. Antineoplastons itself is graded for it.

The grades come from the Natural Medicines database and describe the research so far, not a recommendation, and none of these supplements replaces a prescribed medicine.

Everything Else You Take

See Every Supplement That Interacts With Opicapone

Take other supplements too? 59 supplements have a documented interaction with Opicapone, each explained on its page.

By severity: 2 major, 40 moderate and 17 minor.

The Most Serious There Right Now:

Open the Opicapone interaction pageEvery supplement checked against Opicapone, ranked by severity

Get to Know Each One

About Antineoplastons and Opicapone

Supplement

About Antineoplastons

Antineoplastons are synthetic peptide and amino acid compounds promoted as an alternative cancer treatment, but they are not approved by the FDA and high-quality clinical evidence supporting their effectiveness is lacking. Most studies have been conducted by their developer and have not been independently confirmed. If you are considering them, talk with your oncologist first, and never replace proven cancer treatment with an unproven one.

Full Antineoplastons guide: uses, dosage, safety and every interaction
Safety at a Glance

How Antineoplastons Is Rated

  • Antineoplastons Overall

    Use caution

    Not FDA-approved; effectiveness is unproven and side effects can be serious, especially at high doses.

  • Pregnancy

    Avoid

    There is no reliable safety data, so use during pregnancy should be avoided.

  • Breastfeeding

    Avoid

    Safety while breastfeeding is unknown, so it should be avoided.

Medication

About Opicapone

Brand name: Ongentys

Opicapone (sold as Ongentys capsules) is used along with levodopa/carbidopa in people with Parkinson’s disease who have “off” episodes. These are times when Parkinson’s symptoms return between doses of levodopa.

Opicapone: uses, dosage and side effects Opicapone: interactions with other drugs Taking more than these two? Check Antineoplastons and Opicapone with everything else you take Opicapone NDC codes and packages

More to Explore

More Pairs and Interactions to Check

Keep Checking

Other Drugs & Antineoplastons

Browse every other medication we’ve checked against Antineoplastons — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
0Moderate
0Minor
2,829No known interaction
No Interaction 2,829 drugs checked — show the list
How Much People Look This Up

Where Antineoplastons and Opicapone Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Antineoplastons
Steady interest

#1,257 of 1,458 supplements looked up here in the last 7 days

29 days ago today
Medication Opicapone
Top half

#1,024 of 2,830 medications looked up here in the last 7 days

29 days ago today

A rank of lookups on this site, not of how often either one is used. It counts every visit, automated ones included, and identifies no one.

Questions and Sources

Common Questions and Where This Comes From

Pharmacist Counseling Corner

Taking Antineoplastons and Opicapone Together: Common Questions

Can you take Antineoplastons with Opicapone?
We do not list a known interaction between Antineoplastons and Opicapone. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
Can you take Antineoplastons with Ongentys?
Ongentys is a brand name of opicapone, so the answer is the same as for opicapone. We do not list a known interaction between Antineoplastons and Opicapone. Everything on this page applies to Ongentys too.
Do Antineoplastons and Opicapone have any of the same side effects?
Yes — our sources link each of them separately to 3 of the same effects. That is not a documented interaction, but taken together the same side effect from two sources might be more likely or stronger; no study of the two together says by how much. And if one of those effects turns up, it can be harder to tell which one is behind it. They are listed on this page with the source behind each.
Do other supplements studied for prostate cancer interact with Opicapone?
None of the 3 other supplements the Natural Medicines database grades as having some evidence of a benefit for prostate cancer has a documented interaction with Opicapone. A grade is the research so far, not a recommendation, and no known interaction is not proof of safety; ask your pharmacist before adding one.
Does Opicapone interact with any supplements?
Yes. Opicapone has documented interactions with 59 supplements in our database — Antineoplastons is not one of them. The Opicapone interaction page linked on this page lists every one, ranked by severity.

Written and reviewed by the HelloPharmacist Editorial Team. Our editorial policy

Evidence & Sources

References Cited on This Page

The 11 references the cards above cite, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

Show the 11 references
  1. 20101. Burzynski SR, Mohabbat MO, Burzynski B. Human toxicology studies on oral formulation of Antineoplaston A10. Drugs Exp Clin Res 1984;10(12):891-909.
  2. 25593. Buckner JC, Malkin MG, Reed E, et al. Phase II study of antineoplastons A10 (NSC 648539) and AS2-1 (NSC 620261) in patients with recurrent glioma. Mayo Clin Proc 1999;74(2):137-145. PubMed
  3. 25601. Burzynski SR, Conde AB, Peters A, et al. A retrospective study of antineoplastons A10 and AS2-1 in primary brain tumors. Clin Drug Invest 1999;18(1):1-10.
  4. 25603. Burzynski SR, Lewy RI, Weaver RA, et al. Phase II study of antineoplaston A10 and AS2-1 in patients with recurrent diffuse intrinsic brain stem glioma: a preliminary report. Drugs R D 2003;4(2):91-101. PubMed
  5. 25604. Tsuda H, Hara H, Eriguchi N, et al. Toxicological study on antineoplastons A-10 and AS2-1 in cancer patients. Kurume Med J 1995;42(4):241-249. PubMed
  6. 25607. Burzynski SR, Kubove E. Phase I clinical studies of antineoplaston A3 injections. Drugs Exp Clin Res 1987;13 Suppl 1:17-29.
  7. 25608. Burzynski SR, Kubove E, Burzynski B. Phase I clinical studies of antineoplaston A5 injections. Drugs Exp Clin Res 1987;13 Suppl 1:37-43.
  8. 25610. Burzynski SR, Weaver RA, Lewy RI, et al. Phase II study of antineoplaston A10 and AS2-1 in children with recurrent and progressive multicentric glioma : a preliminary report. Drugs R D 2004;5(6):315-326. PubMed
  9. 25619. Burzynski SR, Burzynski B, Mohabbat MO. Toxicology studies on antineoplaston AS2-1 injections in cancer patients. Drugs Exp Clin Res 1986;12 Suppl 1:25-35.
  10. 25620. Burzynski SR, Kubove E. Toxicology studies on antineoplaston A10 injections in cancer patients. Drugs Exp Clin Res 1986;12 Suppl 1:47-55.
  11. 25622. Burzynski SR, Kubove E, Burzynski B. Phase I clinical studies of antineoplaston A5 injections. Drugs Exp Clin Res 1987;13 Suppl 1:37-43.

All 20 references behind our Antineoplastons records are listed in the Antineoplastons guide.

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is reviewed by the HelloPharmacist Editorial Team. See our data sources and editorial standards.

Where Does Our Data Come From?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
  • Citation library: 105,612 references behind our interaction content, 67,053 of them resolved to verified PubMed/DOI sources. See the references behind this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified November 15, 2026. The Antineoplastons and Opicapone records this page draws on were last updated July 10, 2026.
Data structure & sourcing designed and verified by .
Rating Key

What Our Interaction Ratings Mean

No interaction is on record for this pair. The other supplements and medicines on this page carry a severity rating: how serious an interaction between them is.

See what each severity means

Severity: How Serious Is It?

How clinically significant the interaction is: how much it could affect your health or your treatment.

  • MajorClinically significant. Best to avoid the combination, or use only under close professional supervision.
  • ModerateBe cautious. The combination may call for monitoring, timing changes, or a dose adjustment.
  • MinorLimited clinical concern, but still worth being aware of and mentioning to your pharmacist.
  • No Known InteractionNo documented interaction in our sources.

Still Have a Question About Antineoplastons and Opicapone?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.